HealthcareVor Bio stock rallies post-market on trem-cel study dataBy Helitra.com·September 7, 2024·1 min read Vor Bio stock rallies post-market on trem-cel study data Source: SeekingalphaADVERTISEMENT ADVERTISEMENTBio data postmarket rallies stock study tremcel Vor Post navigation Previous storyaTyr started at buy by Jefferies, citing efzofitimod potentialNext storyAscendis raised to outperform by Oppenheimer ahead of drug launch
Fitness · HealthcareKids Who Got Their First Smartphone at 12 Had 31% Higher Odds of Depression, a Study of 10,588 Children FoundOctober 30, 2026About a third of kids with smartphones first got such a device at the age of 10, but that could be way too…
Health · HealthcareExperts say there’s no single best food for hair growth, but these 8 may helpOctober 30, 2026You probably grew up hearing that you should drink milk to support strong bones. But chances are you weren’t given similar messaging about…
Fitness · HealthcareLead Exposure Can Go Undetected in Children: What Parents Need to KnowOctober 30, 2026Lead poisoning rarely announces itself. A child can have it in their blood and still seem healthy, which is why experts say parents…